Timothée Boyer‐Chammard

Author

Botswana Harvard AIDS Institute Partnership ORCID

Also Known As

AMBITION-cm Study Group, Chammard, Timothée Boyer, Síle Molloy, Sophie Galimard, Timothée Boyer Chammard, Timothée Boyer-Chammard, Timothée Boyer‐Chammard, Youssouf, Nabila, van Widenfelt, Erik

Publications

320

Citations

H-Index

Concepts

All Affiliations

Botswana Harvard AIDS Institute Partnership St George's, University of London Institut Pasteur London School of Hygiene & Tropical Medicine Assistance Publique – Hôpitaux de Paris

About

Timothée Boyer‐Chammard is an author at Botswana Harvard AIDS Institute Partnership.

Timothée Boyer‐Chammard

Publications

184

Citations

H-Index

Page 1

	Year	Citations
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial David S. Lawrence, Nabila Youssouf, Síle F. Molloy, Trials	2018	46
Severe Thrombocytopenia after Zika Virus Infection, Guadeloupe, 2016 Timothée Boyer‐Chammard, Kinda Schepers, Sébastien Breurec, Emerging infectious diseases	2016	40
Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial David S. Lawrence, Charles Muthoga, David B. Meya, The Lancet Global Health	2022	29
Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease Mark W. Tenforde, Timothée Boyer‐Chammard, Charles Muthoga, Journal of Clinical Microbiology	2020	17
Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation study Sayoki Mfinanga, Cecilia Kanyama, Charles Kouanfack, The Lancet HIV	2023	16
Recent advances in managing HIV-associated cryptococcal meningitis Timothée Boyer‐Chammard, Elvis Temfack, Alexandre Alanio, F1000Research	2019	14
Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study Tshepiso Mbangiwa, Aude Sturny-Leclère, Kwana Lechiile, The Lancet Microbe	2024	12
A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration Melanie Alufandika, David S. Lawrence, Timothée Boyer‐Chammard, AIDS	2020	10

Page 1